KANAZAWA UNIVERSITY IMAGE: SUCLA2 GENE IS FREQUENTLY INVOLVED IN THE DELETION OF RB1 GENE REGION, WHICH OCCURS IN 10 – 30 % OF ADVANCED PROSTATE CANCERS. SUCLA2 DELETION GIVES RISE TO A METABOLIC. Kanazawa, Japan – The compound thymoquinone (TQ) selectively kills prostate cancer cells at advanced stages, according to a new study published in Oncogene....
